Nursery,So AWE isn't able to to an off-market deal (perfectly timed of course) with the likes of GS etc in order to get over the line at just the right time?(If anybody else knows, please do comment)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025